Literature DB >> 27045466

Is exogenous hydrogen sulfide a relevant tool to address physiological questions on hydrogen sulfide?

Philippe Haouzi1.   

Abstract

This review challenges the use of solutions of dissolved exogenous H2S in the literature as a tool to determine the potential physiological functions of endogenous H2S as well as its putative therapeutic applications. Our major point of contention is that solutions of dissolved H2S are used in vitro at concentrations, within the high microM range, which are above the concentrations of dissolved H2S found in blood and tissues during lethal H2S exposure in vivo. In addition, since the levels of toxicity are extremely variable among cell types, a property that is seldom acknowledged, the physiological relevance of data obtained after local or in-vitro administrations of H2S at concentrations of few microM is far from certain. Conversely, the rate of disappearance of the dissolved pool of H2S in the body (being trapped or oxidized), which we found to be at least of several micromoles/kg/min, is so rapid in vivo that if relatively low quantities of H2S, i.e. few micromoles for instance, are administered, no change in H2S concentrations in the body is to be expected, unless toxic levels are used. Protocols looking at the effects of compounds slowly releasing H2S must also resolve a similar conundrum, as their effects must be reconciled with the unique ability of the blood and tissues to get rid of H2S and the steepness of the dose-toxic effects relationship. Only by developing a comprehensive framework in which H2S metabolism and toxicity will be used as a rationale to justify any experimental approach will we be able to bring definitive evidence supporting a protective role for exogenous H2S, if any, and its putative function as an endogenous mediator.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gaseous transmitter; Hydrogen sulfide; Toxicology

Mesh:

Substances:

Year:  2016        PMID: 27045466      PMCID: PMC4887406          DOI: 10.1016/j.resp.2016.03.015

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  39 in total

Review 1.  A practical look at the chemistry and biology of hydrogen sulfide.

Authors:  Kenneth R Olson
Journal:  Antioxid Redox Signal       Date:  2012-01-16       Impact factor: 8.401

Review 2.  Hypoxia-induced arterial chemoreceptor stimulation and hydrogen sulfide: too much or too little?

Authors:  Philippe Haouzi; Harold Bell; Andry Van de Louw
Journal:  Respir Physiol Neurobiol       Date:  2011-10-05       Impact factor: 1.931

3.  Cardioprotective effects of hydrogen sulfide.

Authors:  Gábor Szabó; Gábor Veres; Tamás Radovits; Domokos Gero; Katalin Módis; Christiane Miesel-Gröschel; Ferenc Horkay; Matthias Karck; Csaba Szabó
Journal:  Nitric Oxide       Date:  2010-11-19       Impact factor: 4.427

4.  "Hydrogen sulfide oxidation and the arterial chemoreflex: effect of methemoglobin" by Haouzi et al. [Respir. Physiol. Neurobiol. (2011)].

Authors:  Kenneth R Olson
Journal:  Respir Physiol Neurobiol       Date:  2011-07-08       Impact factor: 1.931

5.  Determination of hydrogen sulfide and acid-labile sulfur in animal tissues by gas chromatography and ion chromatography.

Authors:  T Ubuka; T Abe; R Kajikawa; K Morino
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-06-05

6.  Passive loss of hydrogen sulfide in biological experiments.

Authors:  Eric R DeLeon; Gilbrian F Stoy; Kenneth R Olson
Journal:  Anal Biochem       Date:  2011-10-15       Impact factor: 3.365

Review 7.  Hydrogen sulfide and ischemia-reperfusion injury.

Authors:  Chad K Nicholson; John W Calvert
Journal:  Pharmacol Res       Date:  2010-06-11       Impact factor: 7.658

8.  Ferric Iron and Cobalt (III) compounds to safely decrease hydrogen sulfide in the body?

Authors:  Andry Van de Louw; Philippe Haouzi
Journal:  Antioxid Redox Signal       Date:  2012-03-06       Impact factor: 8.401

Review 9.  The therapeutic potential of hydrogen sulfide: separating hype from hope.

Authors:  Kenneth R Olson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-04       Impact factor: 3.619

10.  Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression.

Authors:  Huili Zhang; Changfa Guo; Duojiao Wu; Alian Zhang; Ting Gu; Liansheng Wang; Changqian Wang
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

View more
  6 in total

1.  H2S concentrations in the heart after acute H2S administration: methodological and physiological considerations.

Authors:  Takashi Sonobe; Philippe Haouzi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-16       Impact factor: 4.733

2.  Analysis of decreases in systemic arterial pressure and heart rate in response to the hydrogen sulfide donor sodium sulfide.

Authors:  Kevin W Swan; Bryant M Song; Allen L Chen; Travis J Chen; Ryan A Chan; Bradley T Guidry; Prasad V G Katakam; Edmund K Kerut; Thomas D Giles; Philip J Kadowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-30       Impact factor: 4.733

3.  Methylene Blue Counteracts H2S-Induced Cardiac Ion Channel Dysfunction and ATP Reduction.

Authors:  Joseph Y Cheung; JuFang Wang; Xue-Qian Zhang; Jianliang Song; John M Davidyock; Fabian Jana Prado; Santhanam Shanmughapriya; Alison M Worth; Muniswamy Madesh; Annick Judenherc-Haouzi; Philippe Haouzi
Journal:  Cardiovasc Toxicol       Date:  2018-10       Impact factor: 3.231

Review 4.  Environmental toxicology of hydrogen sulfide.

Authors:  Samantha L Malone Rubright; Linda L Pearce; Jim Peterson
Journal:  Nitric Oxide       Date:  2017-10-07       Impact factor: 4.427

Review 5.  Sulphurous Mineral Waters: New Applications for Health.

Authors:  Jose Manuel Carbajo; Francisco Maraver
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-06       Impact factor: 2.629

6.  Intravenous hydrogen sulfide does not induce neuroprotection after aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury in a human-like porcine model of ubiquitous arteriosclerosis.

Authors:  Andre Bredthauer; Karla Lehle; Angelika Scheuerle; Hubert Schelzig; Oscar McCook; Peter Radermacher; Csaba Szabo; Martin Wepler; Florian Simon
Journal:  Intensive Care Med Exp       Date:  2018-10-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.